Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Onyx Healthcare's EBIT per Share for the
three
months ended in Dec. 2025 was NT$1.38.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$3.23.
During the past 12 months, the average EBIT per Share Growth Rate of Onyx Healthcare was -44.70% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -30.50% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -15.30% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -9.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Onyx Healthcare's EBIT per Share or its related term are showing as below:
ROCO:6569'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -30.5 Med: 2.05 Max: 47.5
Current: -30.5
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Onyx Healthcare was 47.50% per year. The lowest was -30.50% per year. And the median was 2.05% per year.
ROCO:6569's 3-Year EBIT Growth Rate is ranked worse than 92.37% of 524
companies
in the Healthcare Providers & Services industry
Industry Median: 11.95
vs ROCO:6569: -30.50
Onyx Healthcare's EBIT for the
three
months ended in Dec. 2025 was NT$54 Mil.
Onyx Healthcare (ROCO:6569) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Onyx Healthcare EBIT per Share Related Terms
Onyx Healthcare EBIT per Share Historical Data
* Premium members only.
The historical data trend for Onyx Healthcare's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$3.23
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Onyx Healthcare (ROCO:6569) has a EBIT per Share of NT$3.23 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Onyx Healthcare and its competitors. According to the industry distribution chart, Onyx Healthcare ranks #484 out of 524 companies in the Healthcare Providers & Services industry, placing it in the top 92.4%.
Is Onyx Healthcare's EBIT per Share too high?
Onyx Healthcare's current EBIT per Share is NT$3.23. Based on the distribution chart, Onyx Healthcare ranks #484 out of 524 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Onyx Healthcare has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Onyx Healthcare's EBIT per Share compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Onyx Healthcare ranks #484 out of 524 companies for EBIT per Share. This places Onyx Healthcare in the lower half of its industry. The industry median EBIT per Share is 11.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.95, based on 524 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Onyx Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onyx Healthcare's current EBIT per Share is NT$3.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Onyx Healthcare (ROCO:6569) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$121.20, compared to a current price of NT$98.00 — trading 19.1% below its estimated fair value. The current EBIT per Share is NT$3.23. Onyx Healthcare's overall GF Score™ is 78/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Onyx Healthcare (ROCO:6569), the current EBIT per Share is NT$3.23 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Onyx Healthcare (ROCO:6569) Overvalued in 2026?
Based on GuruFocus' analysis, Onyx Healthcare stock appears to be undervalued.
The current stock price of NT$98.00 is trading 19.1% below its estimated GF Value™ of NT$121.20.
GuruFocus considers Onyx Healthcare to be Modestly Undervalued.
Key valuation signals for ROCO:6569:
EBIT per Share: NT$3.23
GF Value™: NT$121.20 vs. price of NT$98.00 (19.1% below fair value)
No single metric tells the full story. See the ROCO:6569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan, the United States, Europe, and Other countries and generates maximum revenue from Taiwan.
78GF Score
Get the complete analysis for ROCO:6569
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6569 has been successfully added to your 
